Reactive oxygen species, cell signaling, and cell injury

Free Radical Biology and Medicine

Volumn 28, Issue 10, 2000, Pages 1456-1462

  Hensley, Kenneth ^a   Robinson, Kent A ^a   Gabbita, S Prasad ^a   Salsman, Scott ^a   Floyd, Robert A ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Antioxidant; Free radical; Inflammation; Nitric oxide; Nitrone; Phosphatase

Indexed keywords

ANTIOXIDANT; FREE RADICAL; NITRIC OXIDE; NITRONE; SCAVENGER;

ALZHEIMER DISEASE; ASTROCYTE; CELL DAMAGE; CONFERENCE PAPER; CYTOLOGY; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; FREE RADICAL SCAVENGERS; HUMANS; INFLAMMATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 0034656849     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00252-5     Document Type: Conference Paper

References (56)

1. Commoner B., Townsend J., Pake G.E. Free radicals in biological materials. Nature. 174:1954;689-691.
2. Boveris A., Chance B. The mitochondrial generation of hydrogen peroxide general properties and effect of hyperbaric oxygen . Biochem. J. 134:1973;707-716.
3. Hensley K., Pye Q.N., Maidt M.L., Stewart C.A., Robinson K.A., Jaffrey F., Floyd R.A. Interaction of α-phenyl-N-tert-butyl nitrone and alternative electron acceptors with complex I indicates a substrate reduction site upstream from the rotenone binding site. J. Neurochem. 71:1998;2549-2557.
4. Stadtman E.R. Metal ion-catalyzed oxidation of proteins biochemical mechanism and biological consequences . Free Radic. Biol. Med. 9:1990;315-325.
5. Stadtman E.R., Berlett B.S. Fenton chemistry. Amino acid oxidation. J. Biol. Chem. 266:1991;17201-17211.
6. Floyd R.A. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis. 11:1990;1447-1450.
7. Gille J.J., van Berkel C.G., Joenje H. Mutagenicity of metabolic oxygen radicals in mammalian cell cultures. Carcinogenesis. 15:1994;2695-2699.
8. Halliwell B. Oxygen and nitrogen are pro-carcinogens. Damage to DNA by reactive oxygen, chlorine and nitrogen species measurement, mechanism and the effects of nutrition . Mutat. Res. 443:1999;37-52.
9. Buettner G.R. The pecking order of free radicals and antioxidants lipid peroxidation, alpha tocopherol and ascorbate . Arch. Biochem. Biophys. 300:1993;535-543.
10. Burton G.W., Joyce A., Ingold K.U. First proof that vitamin E is major lipid-soluble, chain-breaking antioxidant in human blood plasma. Lancet. 2:1982;27.
11. Ingold K.U., Webb A.C., Witter D., Burton G.W., Metcalfe T.A., Muller D.P. Vitamin E remains the major lipid-soluble, chain-breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency. Arch. Biochem. Biophys. 259:1987;224-225.
12. Squadrito G.L., Pryor W.A. Oxidative chemistry of nitric oxide the roles of superoxide, peroxynitrite, and carbon dioxide . Free Radic. Biol. Med. 25:1998;392-403.
13. Koppenol W.H. The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic. Biol. Med. 25:1998;385-391.
14. Gey K.F., Puska P., Moser U.K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53:(Suppl. 1):1991;326S-334S.
15. Stampfer M.J., Hennekens C.H., Manson J.E., Coldizt G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary artery disease in women. N. Engl. J. Med. 328:1993;1444-1449.
16. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328:1993;1450-1456.
17. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
18. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J. Randomised controlled trial of vitamin E in patients with coronary disease Cambridge Heart Antioxidant Study (CHAOS) . Lancet. 347:1996;781-786.
19. Rapola J.M., Virtamo J., Ripatti S., Huttumen J.K., Albanes D., Taylor P.R., Heinonen O.P. Randomised trial of alpha tocopherol and beta carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 349:1997;1715-1720.
20. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330:1994;1029-1035.
21. Cooney R.V., Franke A.A., Harwood P.J., Hatch-Pigott V., Custer L.J., Mordan L.J. α-Tocopherol detoxification of nitrogen dioxide superiority to α-tocopherol . Proc. Natl. Acad. Sci. USA. 90:1993;1771-1775.
22. Christen S., Woodall A.A., Shigenaga M.K., Southwell-Keely P.T., Duncan M.W., Ames B.N. α-Tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol physiological implications . Proc. Natl. Acad. Sci. USA. 94:1997;3217-3222.
23. Goss S.P.A., Hogg N., Kalyanaraman B. The effect of α-tocopherol on the nitration of α-tocopherol by peroxynitrite. Arch. Biochem. Biophys. 363:1999;333-340.
24. Saldeen T., Li D., Mehta J.L. Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J. Am. Coll. Cardiol. 34:1999;1208-1215.
25. Suzuki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22:1997;269-285.
26. Schreck, R.; Rieber, P.; Baeuerle, P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:2247-2258; 1991.
27. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor kappa B an oxidative stress-responsive transcription factor of eukaryotic cells (a review) . Free Radic. Res. Commun. 17:1992;221-237.
28. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., Rhee S.G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272:1997;217-221.
29. Lee S.R., Kwon K.S., Kim S.R., Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273:1998;15366-15372.
30. Robinson K., Stewart C.A., Pye Q.N., Nguyen X., Kenney L., Salsman S., Floyd R.A., Hensley K. Redox sensitive protein phosphatase activity regulates the phosphorylation state of p38 protein kinase in primary astrocyte culture. J. Neurosci Res. 55:1999;724-732.
31. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
32. Denu J.M., Tanner K.G. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide evidence for a sulfenic acid intermediate and implications for redox regulation . Biochemistry. 37:1998;5633-5642.
33. Barrett W.C., DeGnore J.P., Konig S., Fales H.M., Keng Y.F., Zhang Z.Y., Yim M.B., Chock P.B. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry. 18:1999;6699-6705.
34. Robinson K.A., Stewart C.A., Pye Q.N., Floyd R.A., Hensley K. Basal protein phosphorylation is decreased and phosphatase activity increased by an antioxidant and a free radical trap in primary rat glia. Arch. Biochem. Biophys. 365:1999;211-215.
35. Hensley K., Carney J.M., Stewart C.A., Tabatabaie T., Pye Q.N., Floyd R.A. Nitrone-based free radical traps as neuroprotective agents in cerebral ischemia and other pathologies. Int. Rev. Neurobiol. 40:1997;299-317.
36. Baldassare J.J., Bi Y., Bellone C.J. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J. Immunol. 162:1999;5367-5673.
37. Bhat N.R., Zhang P., Lee J.C., Hogan E.L. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor α gene expression in endotoxin-stiumulated primary glial cultures. J. Neurosci. 18:1998;1633-1641.
38. Da Silva J., Pierrat B., Mary J.L., Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric oxide synthase expression in mouse astrocytes. J. Biol. Chem. 272:1997;28373-28380.
39. Hensley K., Floyd R.A., Zheng N.-Y., Nael R., Robinson K.A., Nguyen X., Pye Q.N., Stewart C.A., Geddes J., Markesbery W.R., Patel E., Johnson G.V.W., Bing G. p38 kinase is activated in Alzheimer disease brain. J. Neurochem. 72:1999;2053-2058.
40. Smith M.A., Harris P.L.R., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657.
41. Walton K.M., DiRocco R., Bartlett B.A., Koury E., Marcy V.R., Jarvis B., Shaefer E.M., Bhat R.V. Activation of p38 MAPK in microglia after ischemia. J. Neurochem. 70:1998;1764-1767.
42. Tanaka K., Shirai T., Nagata E., Dembo T., Fukuuchi Y. Immunohistochemical detection of nitrotyrosine in postischemic cortex in gerbil. Neurosci. Lett. 235:1997;85-88.
43. Eliasson M.J., Huang Z., Ferrante R.J., Sasamata M., Molliver M.E., Snyder S.H., Moskowitz M.A. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J. Neurosci. 19:1999;5910-5918.
44. Oliver C.N., Starke-Reed P.E., Stadtman E.R., Liu G.J., Carney J.M., Floyd R.A. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. USA. 87:1990;5144-5147.
45. Carney J.M., Starke-Reed P.E., Oliver C.N., Landum R.W., Cheng M.S., Wu J.F., Floyd R.A. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. Proc. Natl. Acad. Sci. USA. 88:1991;3633-3636.
46. Pogrebniak H.W., Merino M.J., Hahn S.M., Mitchell J.B., Pass H.I. Spin trap salvage from endotoxemia the role of cytokine down-regulation . Surgery. 112:1992;130-139.
47. Miyajima T., Kotake Y. Spin trapping agent, phenyl N-tert-butyl nitrone, inhibits induction of nitric oxide synthase in endotoxin-induced shock in mice. Biochem. Biophys. Res. Commun. 215:1995;114-121.
48. Sang H., Wallis G.L., Stewart C.A., Kotake Y. Expression of cytokines and activation of transcription factors in lipopolysaccharide-administered rats and their inhibition by phenyl N-tert-butylnitrone (PBN). Arch. Biochem. Biophys. 363:1999;341-348.
49. Stewart C.A., Hyam K., Wallis G., Sang H., Robinson K.A., Floyd R.A., Kotake Y., Hensley K. Phenyl-N-tert-butylnitrone demonstrates broad-spectrum inhibition of apoptosis-associated gene expression in endotoxin-treated rats. Arch. Biochem. Biophys. 365:1999;71-74.
50. Hensley K., Williamson K., Gabbita S.P., Grammas P., Floyd R.A. Determination of biological oxidative stress using high performance liquid chromatography with electrochemical detection (HPLC-ECD). J. High Res. Chromatogr. 22:1999;429-437.
51. Hensley K., Maidt M.L., Yu Z.Q., Sang H., Markesbery W.R., Floyd R.A. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J. Neurosci. 18:1998;8126-8132.
52. Hensley K., Maidt M.L., Pye Q.N., Stewart C.A., Wack M., Tabatabaie T., Floyd R.A. Quantitation of protein-bound 3-nitrotyrosine and 3,4-dihydroxyphenylalanine by high-performance liquid chromatography with electrochemical array detection. Anal. Biochem. 251:1997;187-195.
53. Arterbery V.E., Pryor W.A., Jiang L., Sehnert S.S., Foster W.M., Abrams R.A., Williams J.R., Wharam M.D. Jr, Risby T.H. Breath ethane generation during clinical total body irradiation as a marker of oxygen-free-radical-mediated lipid peroxidation a case study . Free Radic. Biol. Med. 17:1994;569-576.
54. Montine T.J., Beal M.F., Cudkowicz M.E., O'Donnell H., Margolin R.A., McFarland L., Bachrach A.F., Zackert W.E., Roberts L.J., Morrow J.D. Increased CSF F2-isoprostane concentration in probable AD. Neurology. 52:1999;562-565.
55. Roberts L.J. II, Montine T.J., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S., Dettbarn W.D., Morrow J.D. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273:1998;13605-13612.
56. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336:1997;1216-1222.